0001415889-24-018159.txt : 20240625
0001415889-24-018159.hdr.sgml : 20240625
20240625171554
ACCESSION NUMBER: 0001415889-24-018159
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240624
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vig Pamela
CENTRAL INDEX KEY: 0001780069
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 241069919
MAIL ADDRESS:
STREET 1: C/O MIRUM PHARMACEUTICALS, INC.
STREET 2: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4-06252024_090650.xml
X0508
4
2024-06-24
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001780069
Vig Pamela
C/O MIRUM PHARMACEUTICALS, INC.
989 E HILLSDALE BLVD., SUITE 300
FOSTER CITY
CA
94404
false
true
false
false
CHIEF SCIENTIFIC OFFICER
1
Common Stock
2024-06-24
4
M
0
30559
2.936
A
57965
D
Common Stock
2024-06-24
4
S
0
30559
34
D
27406
D
Common Stock
75000
I
By The Vig-Ancock Family Trust
Stock Option (right to buy)
2.936
2024-06-24
4
M
0
30559
0
D
2029-03-11
Common Stock
30559
125691
D
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted in March 2024.
The stock option is fully vested.
/s/ Judit Ryvkin, Attorney-in-Fact
2024-06-25